The diagnosis of prostate cancer (PCa) is currently made by histological confirmation from a prostate biopsy guided by altered serum prostate-specific antigen (PSA) values (≥ 4 ng/ml) and/or a suspicious digital rectal examination (DRE) [1–3]. The gene discussed is KLK3; the disease is prostate cancer.